noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Wyoming Department of[...]

Willwood Dam/Shoshone River Work Group 2 Public Meeting
Wyoming Department of[...]

WYOMING STATE REVOLVING FUNDS PUBLIC MEETING
The Office of the Governor of the[...]

Office of the Governor – News Release – Gov. Green Approves $385.4M[...]

Healthcare

Phaxiam Therapeutics SA

04/15/2024 | Press release | Distributed by Public on 04/15/2024 01:13

PHAXIAM Therapeutics annonce le recrutement du premier patient dans l’étude de phase 1 dans l’endocardite infectieuse causée par le Staphylococcus aureus

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Phaxiam Therapeutics SA | News | Health | Science | Research | Finance | Security Markets | Security Markets | Company News | Business Announcement | Products and Services | Securities Issuers | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | OTC Markets | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Euronext Paris | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Aquis Exchange | SIGMA X MTF | Aquis Exchange Europe | Equiduct | Euronext Block MTF | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Turquoise

Back

Download the original document